George Lawrence Mikan III Sells 13,180 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CEO George Lawrence Mikan III sold 13,180 shares of the company's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total value of $91,337.40. Following the sale, the chief executive officer now owns 297,790 shares of the company's stock, valued at $2,063,684.70. This trade represents a 4.24 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

George Lawrence Mikan III also recently made the following trade(s):

• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total value of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total value of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Stock Performance

NYSE NEUE traded down $0.38 during trading hours on Monday, hitting $4.71. 81,052 shares of the company's stock were exchanged, compared to its average volume of 18,693. The business's 50 day moving average is $7.26 and its 200-day moving average is $6.01. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $7.66. The firm has a market capitalization of $38.98 million, a P/E ratio of -0.09 and a beta of 0.56.

Remove Ads

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada decreased their price objective on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research note on Monday, December 9th.

Institutional Investors Weigh In On NeueHealth

A number of large investors have recently modified their holdings of the stock. Virtu Financial LLC acquired a new stake in NeueHealth during the 4th quarter valued at approximately $76,000. Northern Trust Corp lifted its holdings in shares of NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company's stock worth $242,000 after purchasing an additional 13,074 shares during the last quarter. Finally, Partners Group Holding AG bought a new stake in shares of NeueHealth in the 3rd quarter worth approximately $463,000. Institutional investors and hedge funds own 63.88% of the company's stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.